C2C Advanced Systems Limited (NSE:C2C)
India · Delayed Price · Currency is INR 822.20
+58.25 (7.62%)
At close: Aug 12, 2025
Ligand Pharmaceuticals Revenue
In the fiscal year ending March 31, 2024, C2C Advanced Systems had annual revenue of 410.59M INR with 410.13% growth. C2C Advanced Systems had revenue of 216.12M in the quarter ending September 30, 2024.
Revenue
410.59M
Revenue Growth
+410.13%
P/S Ratio
33.32
Revenue / Employee
3.84M
Employees
107
Market Cap
13.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 410.59M | 330.10M | 410.13% |
| Mar 31, 2023 | 80.49M | 77.02M | 2,220.18% |
| Mar 31, 2022 | 3.47M | -7.34M | -67.92% |
| Mar 31, 2021 | 10.81M | -42.68M | -79.79% |
| Mar 31, 2020 | 53.49M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |